Suppr超能文献

[在初级卫生保健中心对2型糖尿病患者进行毛细血管糖化血红蛋白测定]

[Capillary HbA1c determination on type 2 diabetes patients in a primary health centre].

作者信息

Font María Teresa Carrera, Brichs María Claustre Solé, Álvarez María Clara Sala, Olivella Jose María Navarro, Turó Josefina Servent, Fernández María Pilar Felipe

机构信息

Laboratorio Clínico Bon Pastor, SAP Suport al Diagnòstic i al Tractament, Àmbit d'Atenció Primària Barcelona, Institut Català de la Salut, España.

出版信息

Aten Primaria. 2011 Oct;43(10):536-43. doi: 10.1016/j.aprim.2010.09.017. Epub 2011 Mar 15.

Abstract

OBJECTIVE

To determine the reliability and practicability of the point-of-care- test (POCT) analyzer, Afinion, for capillary HbA1c testing. To assess the benefits of its implementation on the intra-annual follow up of type 2 diabetic patients.

DESIGN

Descriptive cross-sectional study. Analytical validation of the Afinion reader.

SETTING

Primary Health Care (CAP Carmel and Bon Pastor Clinic Laboratory).

PARTICIPANTS

A total of 94 type 2 diabetic patients selected according to their previous HbA1c value.

METHODS

We performed one capillary puncture and one venous extraction on each visit. The capillary sample was assessed in real time on the Afinion in the Primary Health Care Centre and the venous sample was sent to Bon Pastor Clinic Laboratory for assessment on an Afinion analyzer and by a high performance liquid chromatrography (HPLC) reference method. Practicability was assesses by both by the operators of the Afinion and the patients using an 11 question questionnaire. The efficiency in terms of process timings was also evaluated.

RESULTS

Intra-serial coefficient of variation (CV) was lower than 1% and inter-serial lower than 3%. The regression analysis showed: Afinion capillary sample=0.95 Afinion venous+0.21. No systematic or proportional error was detected in the 95% confidence interval (95% CI). The comparison between venous HPLC and Afinion showed: Afinion capillary sample=0.80 HPLC+1.14. A statistically significant difference was shown for these values at the 95% CI. Practicability was valued by users from 7 to 9.2 (professionals) and from 7.7 to 9.2 (patients). Implementation of the Afinion capillary method for intra-annual testing in follow up of diabetic patients could result in the saving of 600-900 professional hours/year.

CONCLUSIONS

Afinion seems to be a good choice for the intra-annual determination of HbA1c when compared to the traditional process due to its accessibility, practicability and efficiency. Professionals should know the limitations of the POCT method in order to consider the validity of the results.

摘要

目的

确定即时检验(POCT)分析仪Afinion用于检测毛细血管糖化血红蛋白(HbA1c)的可靠性和实用性。评估其在2型糖尿病患者年度随访中的应用效益。

设计

描述性横断面研究。对Afinion读数仪进行分析验证。

地点

初级卫生保健机构(卡梅尔角和邦帕斯托诊所实验室)。

参与者

根据之前的HbA1c值选取的94例2型糖尿病患者。

方法

每次就诊时,我们进行一次毛细血管穿刺和一次静脉血采集。毛细血管样本在初级卫生保健中心用Afinion即时进行评估,静脉血样本则送往邦帕斯托诊所实验室,用Afinion分析仪并通过高效液相色谱(HPLC)参考方法进行评估。通过Afinion操作人员和患者使用一份包含11个问题的问卷来评估实用性。还评估了流程时间方面的效率。

结果

批内变异系数(CV)低于1%,批间变异系数低于3%。回归分析显示:Afinion毛细血管样本 = 0.95×Afinion静脉样本 + 0.21。在95%置信区间(95%CI)内未检测到系统误差或比例误差。静脉HPLC与Afinion之间的比较显示:Afinion毛细血管样本 = 0.80×HPLC + 1.14。在95%CI时,这些值显示出统计学上的显著差异。用户对实用性的评分在7至9.2分(专业人员)和7.7至9.2分(患者)之间。在糖尿病患者随访中采用Afinion毛细血管法进行年度检测,每年可节省600 - 900个专业工时。

结论

与传统方法相比,Afinion因其可及性、实用性和效率,似乎是年度HbA1c测定的一个不错选择。专业人员应了解POCT方法的局限性,以便考虑结果的有效性。

相似文献

1
[Capillary HbA1c determination on type 2 diabetes patients in a primary health centre].
Aten Primaria. 2011 Oct;43(10):536-43. doi: 10.1016/j.aprim.2010.09.017. Epub 2011 Mar 15.
2
Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.
J Diabetes Sci Technol. 2012 Mar 1;6(2):380-6. doi: 10.1177/193229681200600224.
3
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.
Ann Glob Health. 2018 Nov 5;84(4):618-624. doi: 10.9204/aogh.2368.
4
Evaluation of two HbA1c point-of-care analyzers.
Clin Chem Lab Med. 2011 Apr;49(4):653-7. doi: 10.1515/CCLM.2011.101. Epub 2011 Feb 17.
7
Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data.
Clin Chem Lab Med. 2020 Mar 26;58(4):588-596. doi: 10.1515/cclm-2019-0879.
8
Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction.
J Diabetes Sci Technol. 2018 May;12(3):687-694. doi: 10.1177/1932296818759690. Epub 2018 Mar 13.
9
Accuracy of three hemoglobin A1c point-of-care systems for glucose monitoring in patients with diabetes mellitus.
Endocrinol Nutr. 2015 Dec;62(10):478-84. doi: 10.1016/j.endonu.2015.07.007. Epub 2015 Oct 31.
10
Can the Afinion HbA1c Point-of-Care instrument be an alternative method for the Tosoh G8 in the case of Hb-Tacoma?
Scand J Clin Lab Invest. 2017 Feb;77(1):2-7. doi: 10.1080/00365513.2016.1183261. Epub 2016 May 18.

引用本文的文献

本文引用的文献

1
[Assessment of HbA1c in capillary blood compared to venous blood].
Aten Primaria. 2010 Feb;42(2):126-7; author reply 128. doi: 10.1016/j.aprim.2009.09.016.
2
Diagnosis and classification of diabetes mellitus.
Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S62-9. doi: 10.2337/dc10-S062.
3
Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria.
Clin Chem. 2010 Jan;56(1):44-52. doi: 10.1373/clinchem.2009.130641. Epub 2009 Nov 19.
5
[Assessment of glycosylated hemoglobin in capillary blood compared to venous blood].
Aten Primaria. 2010 Jan;42(1):60-1. doi: 10.1016/j.aprim.2009.03.013. Epub 2009 May 29.
7
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
10
[Evolution of prevalence of type 2 diabetes in adult Spanish population].
Med Clin (Barc). 2007 Sep 15;129(9):352-5. doi: 10.1157/13109554.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验